US 11202819
Use of C-type natriuretic peptide variants to treat osteoarthritis
granted A61KA61K31/573A61K31/728
Quick answer
US patent 11202819 (Use of C-type natriuretic peptide variants to treat osteoarthritis) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Dec 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOMARIN PHARMACEUTICAL INC.
- Grant date
- Tue Dec 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/573, A61K31/728, A61K38/22, A61K38/2242